Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

WCEO vs. MSOS: which is better?

Bottom line

WCEO vs MSOS: the short answer

WCEO (Hypatia Women CEO ETF) and MSOS (AdvisorShares Pure US Cannabis ETF) are both etfs.

Updated Nov 19, 2026

WCEO vs MSOS side by side

WCEOMSOS
TypeETFETF
Fund familyHypatia Women CeoAdvisorshares
CategoryOtherOther
Expense ratio—0.78%
Annual cost per $10k—$78
10-yr cost on $10k (prospectus)—$927
Max front loadNoneNone
12b-1 fee—0%
1-yr return—+23.4%
5-yr return (annualized)—−33.6%
10-yr return (annualized)——
Best quarter—+102.2%
Worst quarter—−50.4%
Net assets (fund)—$1.0B
Number of holdings—61
Portfolio turnover—5%
Returns as of—Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

WCEO and MSOS share none of their top holdings.

WCEO top 10

    MSOS top 10

    1. Curaleaf Holdings Inc — 12.32%
    2. Trulieve Cannabis Corp — 9.56%
    3. Blackrock Treasury Trust — 5.78%
    4. Terrascend Corp — 2.70%
    5. Marex Capital Markets Inc. — 2.16%
    6. Cantor Fitzgerald & Co. — 1.08%
    7. Morgan Stanley & Co. Llc — 0.94%
    8. Glass House Brands Inc — 0.93%
    9. Nomura Securities International, Inc. — 0.85%
    10. Cantor Fitzgerald & Co. — 0.78%

    FAQ

    What is the difference between WCEO and MSOS?
    WCEO (Hypatia Women CEO ETF) and MSOS (AdvisorShares Pure US Cannabis ETF) are both etfs.
    Should I own both WCEO and MSOS?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.